Cozaar XQ Re-examination Study (MK-0954-349)

Organon

Status: Completed

Conditions: Hypertension

Treatments: Drug: amlodipine/losartan

Study type: Observational

Funder types: Industry

Identifiers

NCT01041807

0954-349

2009_004 (Other Identifier)

Details and patient eligibility

About

This survey is conducted for preparing application material for re-examination under the Pharmaceutical Affairs Law and its Enforcement Regulation; its aim is to reconfirm the clinical usefulness of COZAAR XQ through collecting the safety and efficacy information according to the Re-examination Regulation for New Drugs.

Enrollment: 669 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participant with essential hypertension
• Participant who is treated with COZAAR XQ within local label for the first time

Exclusion criteria

• Participant who is treated with COZAAR XQ before contract and out of enrollment period
• Participant who has a contraindication to COZAAR XQ according to the local label

Trial design

669 participants in 1 patient group

All participants

Description:

Participants with hypertension treated with amlodipine/losartan(Cozaar XQ)

Treatment:

Drug: amlodipine/losartan